93 related articles for article (PubMed ID: 3324526)
21. Left ventricular outflow tract gradient decrease with non-surgical myocardial reduction improves exercise capacity in patients with hypertrophic obstructive cardiomyopathy.
Ruzyłło W; Chojnowska L; Demkow M; Witkowski A; Kuśmierczyk-Droszcz B; Piotrowski W; Rausinska L; Karcz M; Małecka L; Rydlewska-Sadowska W
Eur Heart J; 2000 May; 21(9):770-7. PubMed ID: 10739733
[TBL] [Abstract][Full Text] [Related]
22. [Effects of verapamil on systolic time intervals and relaxation time in hypertrophic cardiomyopathy (author's transl)].
Hirose K; Shimada T; Matsumura T; Iwata M; Yasunaga K; Hori K; Matsusaka J
J Cardiogr; 1981 Dec; 11(4):1223-32. PubMed ID: 7201494
[TBL] [Abstract][Full Text] [Related]
23. [Beta-adrenergic blockers and calcium antagonists in hypertrophic cardiomyopathy].
Korovina EP
Klin Med (Mosk); 1998; 76(12):30-5. PubMed ID: 10067289
[TBL] [Abstract][Full Text] [Related]
24. [Myocardial hypertrophy: regression in hypertrophic cardiomyopathies?].
Kuhn H
Z Kardiol; 1985; 74 Suppl 7():179-85. PubMed ID: 4090586
[TBL] [Abstract][Full Text] [Related]
25. Verapamil and beta-adrenoceptor blockade in the treatment of stable angina pectoris.
Hansen JF; Grytter C; Thomsen S; Sigurd B
Clin Exp Pharmacol Physiol Suppl; 1982; 6():31-41. PubMed ID: 6126287
[TBL] [Abstract][Full Text] [Related]
26. [Risk of stress-induced ventricular arrhythmias in hypertrophic cardiomyopathy].
Lösse B; Christoph I; Borggrefe M; Königer HH
Z Kardiol; 1984 May; 73(5):304-12. PubMed ID: 6541405
[TBL] [Abstract][Full Text] [Related]
27. Hypertrophic occlusive cardiomyopathy.
Kaltenbach M; Hopf R
Clin Invest Med; 1980; 3(1-2):179-84. PubMed ID: 7008998
[No Abstract] [Full Text] [Related]
28. [Echocardiographic parameters in hypertrophic cardiomyopathy during verapamil treatment (author's transl].
Lemke R; Hopf R; Kober G; Kaltenbach M
Z Kardiol; 1980 Oct; 69(10):661-8. PubMed ID: 7192909
[No Abstract] [Full Text] [Related]
29. Hypertrophic cardiomyopathy: long-term effects of propranolol versus verapamil in preventing sudden death in "low-risk" patients.
Pelliccia F; Cianfrocca C; Romeo F; Reale A
Cardiovasc Drugs Ther; 1990 Dec; 4(6):1515-8. PubMed ID: 2081144
[TBL] [Abstract][Full Text] [Related]
30. The clinical and hemodynamic effects of propranolol, pindolol and verapamil in the treatment of exertional angina pectoris.
Johnston DL; Manyari DE; Kostuk WJ
Can Med Assoc J; 1984 Jun; 130(11):1449-55. PubMed ID: 6145515
[TBL] [Abstract][Full Text] [Related]
31. Progressive decrease of outflow gradient and septum thickness after percutaneous alcoholization of the interventricular septum in hypertrophic obstructive cardiomyopathy.
Airoldi F; Di Mario C; Catanoso A; Dharmadhikari A; Tzifos V; Anzuini A; Carlino M; Briguori C; Montorfano M; Vaghetti M; Tolaro S; Colombo A
Ital Heart J; 2000 Mar; 1(3):200-6. PubMed ID: 10806987
[TBL] [Abstract][Full Text] [Related]
32. [Experience with the treatment of patients with hypertrophic cardiomyopathy with obsidan and isoptin].
Kisliak OA; Storozhakov GI
Kardiologiia; 1984 Aug; 24(8):27-30. PubMed ID: 6238196
[TBL] [Abstract][Full Text] [Related]
33. Acute left ventricular filling time and rate changes in hypertrophic cardiomyopathy after verapamil and propranolol evaluated by nuclear stethoscope.
Cocchieri M; Chiuini E; Giaimo MD; Boschetti E; Solinas P
G Ital Cardiol; 1985 Mar; 15(3):307-9. PubMed ID: 4040486
[TBL] [Abstract][Full Text] [Related]
34. Verapamil therapy: a new approach to pharmacologic treatment of hypertrophic cardiomyopathy.
Rosing DR; Kent KM; Maron BJ; Condit J; Epstein SE
Chest; 1980 Jul; 78(1 Suppl):239-47. PubMed ID: 6995039
[TBL] [Abstract][Full Text] [Related]
35. [Acute effects of propranolol on the abnormal diastolic hemodynamics of the left ventricle in hypertrophic cardiomyopathy (author's transl)].
Koga Y; Akiyoski T; Nagae K; Mizobuchi H; Toshima H
Kokyu To Junkan; 1978 May; 26(5):473-6. PubMed ID: 351757
[No Abstract] [Full Text] [Related]
36. Comparable effects of oral diltiazem and verapamil in the treatment of hypertrophic cardiomyopathy. Double-blind crossover study.
Toshima H; Koga Y; Nagata H; Toyomasu K; Itaya K; Matoba T
Jpn Heart J; 1986 Sep; 27(5):701-15. PubMed ID: 3546779
[TBL] [Abstract][Full Text] [Related]
37. Usefulness of Doppler echocardiography for determining hemodynamic improvement with intravenous verapamil in hypertrophic cardiomyopathy.
Cooper M; Shaddy R; Silverman N; Enderlein M
Am J Cardiol; 1985 Jul; 56(1):201-2. PubMed ID: 4040320
[No Abstract] [Full Text] [Related]
38. [Hypertrophic cardiomyopathy during ACTH treatment].
Tacke E; Kupferschmid C; Lang D
Klin Padiatr; 1983 Mar; 195(2):124-8. PubMed ID: 6304397
[TBL] [Abstract][Full Text] [Related]
39. Verapamil therapy in infants with hypertrophic cardiomyopathy.
Moran AM; Colan SD
Cardiol Young; 1998 Jul; 8(3):310-9. PubMed ID: 9731645
[TBL] [Abstract][Full Text] [Related]
40. A cohort study of childhood hypertrophic cardiomyopathy: improved survival following high-dose beta-adrenoceptor antagonist treatment.
Ostman-Smith I; Wettrell G; Riesenfeld T
J Am Coll Cardiol; 1999 Nov; 34(6):1813-22. PubMed ID: 10577575
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
